📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

DUB be good to me. (2022)

First Author: Liu X

Attributed to: Development of LRRK2 PROTAC degraders as chemical probes and potential lead compounds for the treatment of Parkinson's disease funded by Horizon Europe Guarantee

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41589-022-00978-9

PubMed Identifier: 35210617

Publication URI: http://europepmc.org/abstract/MED/35210617

Type: Journal Article/Review

Volume: 18

Parent Publication: Nature chemical biology

Issue: 4

ISSN: 1552-4450